‘Wolverine’ peptide claims to accelerate healing and recovery - NewsNation
High confidence: full text extraction produced 3117 characters.
(NewsNation) — In the Marvel “X-Men” franchise, Wolverine heals from major injuries at supernatural speed. An experimental peptide claims it provides the same superhero-style capabilities.
BPC-157, or its trendier moniker, the “Wolverine” peptide, has seen its popularity surge recently despite never gaining approval from the U.S. Food and Drug Administration. The peptide has garnered the support of HHS Secretary Robert F. Kennedy Jr., who in July encouraged a panel of FDA advisors to allow pharmacy compounding of the supplement.
What is the ‘Wolverine’ peptide?
Social media posts suggest the “Wolverine” peptide benefits muscle growth and injury recovery. Users often take it with TB-500 to gain better results, known as the “Wolverine stack.”
Analysis from a data analytics firm, nference, found 1,039 patients utilized the peptide under a doctor’s supervision. The peptide’s users have since exploded, according to researchers. Between 2020 and 2026, those numbers have risen 33-fold.
“There was no placebo or untreated comparator, and there was no standardized indication, formulation, dose, route, treatment duration, or outcome assessment,” University of Utah’s Dr. Flynn McGuire said of the analysis.
‘Wolverine’ peptide brought improved results
The researchers also noted that the unapproved compound’s new consumers increased from 57% to 70% over the last six years. Out of nearly 1,000 BPC-157 users with recorded race, 96% were white.
Among another 644 patients analyzed who were given the peptide, doctors noted symptom improvement from conditions ranging from sports injuries and chronic pain to gastrointestinal disorders.
Some participants did acknowledge adverse effects when taking the compound, including neuropsychiatric, dermatologic and gastrointestinal symptoms.
“People need to understand that there’s a huge difference between peptides that have been rigorously studied and approved as medications, such as insulin and GLP-1 weight-loss drugs, and these newer compounds,” said Dr. Christopher Robinson, Johns Hopkins University School of Medicine.
“These other peptides haven’t been adequately studied in humans and aren’t approved by the Food and Drug Administration. Anyone who uses them needs to understand the risks.”
Peptides’ popularity continues to grow
Peptides, short for chains of amino acids that act as messengers in the body, have become the internet’s latest wonder product, promoted by celebrities from Khloe Kardashian to Joe Rogan for everything from building muscle to getting a glowing tan.
Kennedy Jr. has also promoted their use, saying on Joe Rogan’s podcast “The Joe Rogan Experience” that he’s used peptides himself “with really good effect on a couple of injuries.”
Peptides like TB-500 and BPC-157 are also favored among bodybuilders.
The peptide industry could quickly become a $2 billion to $3 billion market if legitimized, according to analysts’ estimations. That prediction comes as the compounding industry has been valued at $6.8 billion and will nearly double over the next decade.
NewsNation’s Jesse Weber and Tatiana Carter contributed to this report.